The following is a summary of “Treating chronic kidney disease in Danish primary care: results from the observational ATLAS study,” published in the February 2025 issue of BMC Primary Care by ...

An FDA-approved medication already used to treat people who have type 2 diabetes and chronic kidney disease may also help ...

Learn how chronic kidney disease and diabetes accelerate heart risk, with new research revealing early warning signs.

A year after guidelines were revised to remove the use of race in eGFR, many labs and pathologists were still relying on the ...

GLP-1 medications are renowned for their ability to treat type 2 diabetes and aid weight loss. Now, there's a new benefit to ...

Body-weight cycling, sometimes referred to as yo-yo dieting, may be harmful to the kidneys for people with type 1 diabetes, according to retrospective data analysis.

A new thesis from Karolinska Institutet aims to advance our understanding of the bidirectional relationship between ...

Efficacy was established based on the time to first occurrence of a primary composite endpoint event, defined as onset of persistent 50% or greater reduction in eGFR according to the Chronic Kidney ...

Investigators compared the outcomes of patients with type 2 diabetes who continued versus stopped metformin after progressing to stage 4 chronic kidney disease.

These and other GLP1-RA diabetes/weight-loss meds can also boost outcomes for folks battling chronic kidney disease, new ...

Body-weight Cycling and Risk of Diabetic Kidney Disease in People With Type 1 Diabetes in the DCCT/EDIC Population. The Journal of Clinical Endocrinology & Metabolism , 2025; DOI: 10.1210/clinem ...